Polaryx Therapeutics, Inc. (PLYX) SEC filings
PLYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.60−0.07 (-4.19%)
Close on Nov 17, 2026Market cap $79.75MP/E –Yield –
SEC filings
10 of Polaryx Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 1, 2026 | Sep 1, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 10, 2026 | Jul 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 19, 2026 | Jul 21, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2026 | Jul 17, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 24, 2026 | SEC EDGAR |
See a number that looks wrong?